Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384993 · ClinicalTrials.gov registry record · NA
aeRobic Exercise and Cognitive Health
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02384993 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 24 participants.
The verdict
NCT02384993, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the aeRobic Exercise and Cognitive Health (REACH) study is to understand how an aerobic exercise intervention might help promote brain health and cognition, thereby delaying the onset of clinical symptoms of Alzheimer's disease.
Interventions
- BEHAVIORAL Enhanced Physical Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-04-28 |
| Est. Completion | 2016-07-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02384993
The ClinicalTrials.gov registry entry for NCT02384993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhanced Physical Activity is the first listed.
NCT02384993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02384993 about?
NCT02384993 is a clinical study titled "aeRobic Exercise and Cognitive Health". The purpose of the aeRobic Exercise and Cognitive Health (REACH) study is to understand how an aerobic exercise intervention might help promote brain health and cognition, thereby delaying the onset of clinical symptoms of Alzheimer's disease.
What is the current status of trial NCT02384993?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-04-28. Estimated completion is 2016-07-19.
What interventions are being tested in trial NCT02384993?
The interventions under investigation include: Enhanced Physical Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT02384993?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.